Dr. Patrick Morgante, DO

NPI: 1881655371
Total Payments
$408,992
2024 Payments
$408,806
Companies
6
Transactions
16
Medicare Patients
8,736
Medicare Billing
$645,860

Payment Breakdown by Category

Research$407,316 (99.6%)
Travel$1,184 (0.3%)
Food & Beverage$461.87 (0.1%)
Education$29.99 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $407,316 2 99.6%
Travel and Lodging $1,184 3 0.3%
Food and Beverage $461.87 10 0.1%
Education $29.99 1 0.0%

Payments by Type

Research
$407,316
2 transactions
General
$1,676
14 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $407,316 2 $0 (2024)
ModernaTX, Inc. $1,490 8 $0 (2024)
Organon LLC $69.38 2 $0 (2022)
GlaxoSmithKline, LLC. $44.73 2 $0 (2017)
Boston Scientific Corporation $41.76 1 $0 (2023)
Allergan Inc. $29.99 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $408,806 10 Eli Lilly and Company ($407,316)
2023 $41.76 1 Boston Scientific Corporation ($41.76)
2022 $69.38 2 Organon LLC ($69.38)
2018 $29.99 1 Allergan Inc. ($29.99)
2017 $44.73 2 GlaxoSmithKline, LLC. ($44.73)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/14/2024 ModernaTX, Inc. Travel and Lodging In-kind items and services $531.06 General
09/14/2024 ModernaTX, Inc. Travel and Lodging In-kind items and services $412.95 General
09/14/2024 ModernaTX, Inc. Travel and Lodging In-kind items and services $240.00 General
09/14/2024 ModernaTX, Inc. Food and Beverage In-kind items and services $120.00 General
09/14/2024 ModernaTX, Inc. Food and Beverage In-kind items and services $81.00 General
09/14/2024 ModernaTX, Inc. Food and Beverage In-kind items and services $45.00 General
09/14/2024 ModernaTX, Inc. Food and Beverage In-kind items and services $30.00 General
09/14/2024 ModernaTX, Inc. Food and Beverage In-kind items and services $30.00 General
09/10/2024 Eli Lilly and Company Cash or cash equivalent $404,818.00 Research
Study: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE
06/04/2024 Eli Lilly and Company In-kind items and services $2,498.22 Research
Study: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE
09/29/2023 Boston Scientific Corporation WaveWriter Alpha Prime 16 (Device) Food and Beverage In-kind items and services $41.76 General
Category: WaveWriter Alpha_NMD
02/16/2022 Organon LLC NEXPLANON (Drug) Food and Beverage In-kind items and services $34.69 General
Category: ETONOGESTREL
02/16/2022 Organon LLC NEXPLANON (Drug) Food and Beverage In-kind items and services $34.69 General
Category: ETONOGESTREL
03/07/2018 Allergan Inc. VRAYLAR (Drug) Education In-kind items and services $29.99 General
Category: NEUROSCIENCE
12/13/2017 GlaxoSmithKline, LLC. FLULAVAL (Biological), SHINGRIX Food and Beverage In-kind items and services $23.83 General
Category: VACCINES
11/17/2017 GlaxoSmithKline, LLC. FLUARIX (Biological), FLULAVAL, SHINGRIX Food and Beverage In-kind items and services $20.90 General
Category: VACCINES

Research Studies & Clinical Trials

Study Name Company Amount Records
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EVENT-DRIVEN STUDY TO INVESTIGATE THE EFFECT OF RETATRUTIDE ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND THE DECLINE IN KIDNEY FUNCTION IN PARTICIPANTS WITH BODY MASS INDEX GREATER THAN 27 KG M2 AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND OR CHRONIC KIDNEY DISEASE Eli Lilly and Company $407,316 2

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 949 1,666 $314,010 $82,292
2022 34 2,399 4,186 $486,416 $207,745
2021 36 2,297 4,099 $350,995 $179,350
2020 36 3,091 5,326 $450,042 $176,473
Total Patients
8,736
Total Services
15,277
Medicare Billing
$645,860
Procedure Codes
126

All Medicare Procedures & Services

126 procedure records from CMS Medicare Utilization — Page 1 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 348 748 $168,900 $56,849 33.7%
99285 Emergency department visit with high level of medical decision making Facility 2023 46 46 $78,838 $5,963 7.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 70 81 $13,485 $4,953 36.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 27 27 $4,590 $3,298 71.8%
90662 Influenza vaccine split virus, preservative free Office 2023 45 45 $2,475 $2,426 98.0%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 26 26 $28,183 $2,327 8.3%
96372 Injection of drug or substance under skin or into muscle Office 2023 60 152 $5,784 $1,442 24.9%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2023 23 24 $1,800 $1,399 77.7%
99497 Advance care planning, first 30 minutes Office 2023 20 20 $1,726 $1,192 69.1%
G0008 Administration of influenza virus vaccine Office 2023 47 47 $940.00 $921.20 98.0%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 18 18 $451.00 $311.58 69.1%
83036 Hemoglobin a1c level Office 2023 29 30 $796.00 $285.60 35.9%
36415 Insertion of needle into vein for collection of blood sample Office 2023 29 31 $350.00 $260.40 74.4%
80053 Blood test, comprehensive group of blood chemicals Office 2023 16 17 $463.00 $175.95 38.0%
81002 Urinalysis, manual test Office 2023 33 42 $294.00 $143.22 48.7%
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count Office 2023 18 18 $388.00 $136.98 35.3%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 20 22 $2,266 $123.80 5.5%
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg Office 2023 11 45 $900.00 $51.26 5.7%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 31 188 $900.00 $16.66 1.9%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2023 32 39 $481.00 $15.67 3.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 581 1,547 $303,840 $127,671 42.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 209 310 $38,970 $18,002 46.2%
90670 Pneumococcal vaccine, 13-valent Office 2022 28 28 $7,000 $6,822 97.5%
90662 Influenza vaccine split virus, preservative free Office 2022 118 118 $6,490 $6,366 98.1%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2022 35 35 $5,856 $5,791 98.9%

About Dr. Patrick Morgante, DO

Dr. Patrick Morgante, DO is a Family Medicine healthcare provider based in Havelock, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881655371.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Morgante, DO has received a total of $408,992 in payments from pharmaceutical and medical device companies, with $408,806 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "" ($407,316).

As a Medicare-enrolled provider, Morgante has provided services to 8,736 Medicare beneficiaries, totaling 15,277 services with total Medicare billing of $645,860. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Havelock, NC
  • Active Since 04/01/2006
  • Last Updated 11/20/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1881655371

Products in Payments

  • NEXPLANON (Drug) $69.38
  • WaveWriter Alpha Prime 16 (Device) $41.76
  • VRAYLAR (Drug) $29.99
  • FLULAVAL (Biological) $23.83
  • FLUARIX (Biological) $20.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Havelock